RFK Jr. Is Definitely Coming for Your Vaccines (Part 8): “Massive Epidemic of Vaccine Injury,” ACIP, and a Prominent Oncologist

Key Takeaways

• RFK Jr. pushes anti‑vaccine agenda within HHS.
• Dr. Wafik El‑Deiry joins antivax roundtable.
• MAHA Institute event precedes ACIP meeting on vaccine injuries.
• Panel includes prominent antivax figures like Bigtree and Holland.
• Potential shift could influence CDC vaccine recommendations.

Summary

Robert F. Kennedy Jr., now HHS Secretary, is intensifying his anti‑vaccine campaign by supporting a MAHA Institute roundtable titled “Massive Epidemic of Vaccine Injury.” The event, held in Washington, D.C., features oncologist Dr. Wafik El‑Deiry alongside well‑known antivax activists such as Del Bigtree and Mary Holland. It appears timed to seed discussion ahead of the CDC’s Advisory Committee on Immunization Practices (ACIP) meeting, where vaccine‑injury topics will be on the agenda. Critics warn the gathering could undermine scientific consensus and reshape future vaccine recommendations.

Pulse Analysis

The resurgence of an anti‑vaccine narrative inside the highest levels of U.S. health policy marks a stark departure from decades of evidence‑based public‑health strategy. Robert F. Kennedy Jr., leveraging his role as Secretary of Health and Human Services, has aligned with the MAHA Institute to host a roundtable that frames routine immunizations as a looming crisis. By branding COVID‑19 vaccine side effects as a "massive epidemic," the event seeks to legitimize fringe claims and mobilize media attention, setting the stage for policy debates that could echo beyond the immediate controversy.

Central to this effort is Dr. Wafik El‑Deiry, a respected oncologist whose early work on tumor‑suppressor pathways earned him academic acclaim. His recent partnership with outspoken antivax personalities—Del Bigtree, Mary Holland, and others—signals a troubling erosion of scientific credibility. When a figure with peer‑reviewed credentials endorses speculative mechanisms linking mRNA vaccines to cancer, it blurs the line between rigorous research and conspiracy‑driven rhetoric, potentially swaying other clinicians and policymakers who rely on expert opinion.

The timing of the roundtable, just days before the CDC’s Advisory Committee on Immunization Practices convenes, suggests a strategic attempt to influence the agenda. Should ACIP entertain the “vaccine injury” narrative, future recommendations could be softened, affecting school entry requirements, travel protocols, and public‑health funding. Such a shift would not only jeopardize herd immunity against existing pathogens but also set a precedent for politicized health decisions, underscoring the need for transparent, data‑driven deliberations to safeguard public trust.